Novavax, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the provision of development of recombinant nanoparticle vaccines and adjuvants. Its product pipeline targets infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus, seasonal influenza, pandemic influenza, and Ebola virus. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Recent Equity Price Chart

Loading...

Bullish Trades

Call trades that are bought on or above the market's asking price OR put trades that are sold on or less than the market's bid price - expecting a move to the updside.



Type Expiration DTE Bid Purchase Price Ask Spread Strike Total Traded Size Volume Trade Condition Timestamp Notes
Call Login To View Login To View Login To View Login To View Login To View Login To View Login To View $15,929.00 Login To View Login To View 14 days ago Login To View